Compared to Semaglutide (often sold under the brand name Wegovy), Retatrutide has the potential to offer more comprehensive results for certain individuals
Research currently in progress at ACHI suggests a large portion of Medicaid and private insurance enrollees with obesity in Arkansas similarly have comorbidities that could be treated with GLP-1s
It is also chosen by those who are unable to use the FDA-approved versions due to specific health reasons or other factors like allergic to any component of the drug (for example, dye)) or inability to take the drug in solid oral form such as tablets or capsule (which often occurs in children and elders), or if the physicians believe that the drug is not medically appropriate to treat the patient
Why Physician Supervision Matters GLP-1 medications can be highly effective, but they should be managed with clinical oversight
Strategy 15: consider temporary dose reduction If fatigue significantly impairs your quality of life and does not respond to the strategies above, discuss a temporary dose reduction with your healthcare provider
PlexusDx recommends tracking non-scale victories alongside weight during the first month: increased energy, better sleep, reduced bloating, and improved appetite control